Key result
Including any obesity index in SCORE2 improves risk reclassification for 20-year ASCVD.
Why the study?
Despite the established link between obesity and cardiovascular disease, the optimal anthropometric index for risk prediction remains uncertain.
Does the inclusion of obesity indices in the SCORE2 model improve the prediction and reclassification of 20-year ASCVD risk in healthy adults?
Cohort (n=3,042)
No
Does the inclusion of obesity indices in the SCORE2 model improve the prediction and reclassification of 20-year ASCVD risk in healthy adults?
Answers are grounded in this paper and cite their sources.
Obesity indices enhance the predictive accuracy and risk reclassification of the SCORE2 model for 20-year ASCVD risk in the general population.
BACKGROUND: Despite the established link between obesity and cardiovascular disease (CVD), the optimal anthropometric index for risk prediction remains uncertain. AIMS: This prospective cohort study aimed to compare various anthropometric indices for their association with 20-year atherosclerotic cardiovascular disease (ASCVD) risk in a healthy adult population and to assess their incremental predictive value. METHODS: In 2002, n = 3,042 adults free of CVD, residing in Athens metropolitan area, in Greece, were recruited. A 20-year follow-up was conducted in 2022, comprising n = 2,169 participants, of which n = 1,845 had complete data on both CVD occurrence and anthropometric measures. RESULTS: Almost all the studied anthropometric measures were significantly associated with 20-year ASCVD incidence. However, after full adjustment, none of these measures retained a significant association. The inclusion of any individual obesity index within the SCORE2 model enhanced the model's discriminatory power, while the continuous NRI exhibited positive values, suggesting improved risk reclassification. The indices linked to adipose tissue dysfunction exhibited greater efficacy in distinguishing and reclassifying CVD risk beyond SCORE2. Stratified analysis according to obesity and metabolic health status revealed that the optimal obesity index varies according to individual obesity and metabolic health profiles. CONCLUSION: Obesity indices are strongly associated with long-term risk of ASCVD, underscoring the major role of excessive body fat in the pathogenesis of this condition. The inclusion of an obesity index in a CVD risk model significantly enhances its predictive accuracy and reclassification of risk, emphasizing the importance of these indices in refining CVD risk assessment among the general population.
No takes yet. Share an insight, caveat, or question.
Giannakopoulou et al. (2025) conducted a cohort in Cardiovascular disease risk (n=3,042). Anthropometric indices (obesity indices) vs. SCORE2 model alone was evaluated on 20-year atherosclerotic cardiovascular disease (ASCVD) incidence. The inclusion of any individual obesity index within the SCORE2 model enhanced its discriminatory power and improved risk reclassification for 20-year ASCVD incidence.
Synapse has enriched 10 related papers. Consider them for comparative context: